Clean energy firm Malaysia’s Solarvest Holdings Bhd. has secured a contract from Dexcom Malaysia Sdn Bhd to install a 3.6 megawatt-peak (MWp) solar photovoltaic (PV) system at its manufacturing facility in Batu Kawan, Penang. The facility in Batu Kawan will be the first overseas facility of Dexcom’s US parent, Dexcom Inc, a provider of continuous glucose monitoring systems
In a statement, Solarvest said, “It will serve as the engineering, procurement, construction, and commission (EPCC) provider for the installation of rooftop solar PV for the main building facilities and carpark.”
With the expected generation of 3.6 MWp of clean energy, Dexcom will offset 3,190 tonnes of carbon dioxide, said the statement.
Solarvest’s Executive Director & Group CEO Davis Chun Shiong, “The facility is expected towards Dexcom’s overseas expansion ESG initiatives while optimising operational cost. The growing recognition of sustainability’s significance in business operations has led to a surge in the adoption of clean energy by corporates.” “As a result, our job pipeline remains strong, with a tender book of approximately 2.5 gigawatts (GW) across Malaysia, Taiwan, Philippines, Vietnam, Indonesia, Singapore, and Thailand,” he said.
He added, “The company has plans to boost its current unbilled order book of RM550mil by leveraging on the release of the 800 MW solar PV assets quota under the corporate green power programme.”